Hak Choy, MD
Simmons Cancer Center · Vanderbilt-Ingram Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hak Choy, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:05 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT00851877 · Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck CancerUniversity of Texas Southwestern Medical Center · completed · Head and Neck Cancer · principal investigator
- Ph1/Ph2NCT00547443 · Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerUniversity of Texas Southwestern Medical Center · withdrawn · Lung Cancer · study chair
- Ph3NCT00533949 · High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryRadiation Therapy Oncology Group · completed · Lung Cancer, Radiation Toxicity · study chair
- Ph2NCT00004202 · Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung CancerSpectrum Pharmaceuticals, Inc · completed · Lung Cancer · study chair
- Ph1NCT00016315 · Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung CancerRadiation Therapy Oncology Group · completed · Lung Cancer · study chair
- Ph3NCT00055887 · Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung CancerSpectrum Pharmaceuticals, Inc · withdrawn · Lung Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.